These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36796755)

  • 1. Global or local: The future of biotech.
    Tse V; Schweizer L
    Drug Discov Today; 2023 May; 28(5):103528. PubMed ID: 36796755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swiss Startup Framework: A Highly Effective Network Supporting the Generation of Emerging Biotech Businesses.
    Mitchell I; Steiner S; Altorfer M; Suter-Dick L
    Chimia (Aarau); 2020 Oct; 74(10):765-767. PubMed ID: 33115556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
    Blanco-García E
    MEDICC Rev; 2020 Jan; 22(1):11-16. PubMed ID: 32327617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A venture capital view of challenges, opportunities, and innovation in biomedical research.
    Ratcliffe LT
    Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sticking to the knitting: CIHR, innovation and Canadian biotech.
    Edelson J
    Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotech's perfect storm.
    Karberg S
    Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Market entry and exit by biotech and device companies funded by venture capital.
    Burns LR; Housman MG; Robinson CA
    Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods of biotechnology Biotech BioBrawl: A competition-based learning approach to biotechnology.
    Skiados N; Rehman RS; Riley M; Schroeder KT
    Biochem Mol Biol Educ; 2024; 52(3):332-339. PubMed ID: 38348907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial risk of the biotech industry versus the pharmaceutical industry.
    Golec J; Vernon JA
    Appl Health Econ Health Policy; 2009; 7(3):155-65. PubMed ID: 19799470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaking Up Biotech/Pharma: Can Cues Be Taken from the Tech Industry?
    Wang CK
    SLAS Technol; 2017 Jun; 22(3):233-236. PubMed ID: 28298148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerative medicine in Europe: global competition and innovation governance.
    Hogarth S; Salter B
    Regen Med; 2010 Nov; 5(6):971-85. PubMed ID: 21082895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next biotech plants: new traits, crops, developers and technologies for addressing global challenges.
    Ricroch AE; Hénard-Damave MC
    Crit Rev Biotechnol; 2016 Aug; 36(4):675-90. PubMed ID: 25641327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian Biotech Bazaar: a swot analysis.
    Kumar A
    Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products.
    Hafer N; Buchholz B; Dunlap D; Fournier B; Latham S; Picard MA; Tello S; Gibson L; Lilly CM; McManus DD
    J Clin Transl Sci; 2021; 5(1):e119. PubMed ID: 34267946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.